Assess Satisfaction of Patients and Physicians With Results of Yaz Plus Treatment for 13 Cycles

Bayer

Status: Completed

Conditions: Contraception

Treatments: Drug: BAY98-7071_EE20/DRSP/L-5-MTHF

Study type: Observational

Funder types: Industry

Identifiers

NCT02159261

YZ1410RU (Other Identifier)

17177

Details and patient eligibility

About

Local prospective multicenter non-comparative non-interventional observational study. It's planed to assess satisfaction of patients and physicians with results of Yaz Plus treatment for 13 cycles in real practice.

Full description

Non-interventional, Yaz Plus, Contraception, Assess satisfaction, Russian Federation.

Enrollment: 1,500 patients

Sex: Female

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Female patients ≥ 18 years old
• Requiring contraception
• Prescribed with Yaz Plus for the first time

Exclusion criteria

• Contraindications for the use of Yaz Plus in accordance with the local product information

Trial design

1,500 participants in 1 patient group

Cohort 1

Description:

Female patients ≥ 18 years old requiring contraception.

Treatment:

Drug: BAY98-7071_EE20/DRSP/L-5-MTHF